Salvia hispanica (chia) flour and indicators of metabolic syndrome in outpatients with dyslipidemia

Farinha de chia e síndrome metabólica em pacientes com dislipidemia

Authors

  • Oswaldo Italo ZAPATA SEQUEIROS LIMA
  • Óscar Gustavo HUAMÁN GUTIERREZ
  • Luis Pavel PALOMINO QUISPE

DOI:

https://doi.org/10.12873/444zapata

Keywords:

'Metabolic syndrome', Dyslipidemia

Abstract

Introduction:

Metabolic syndrome is a global problem, increasing the risk of cardiovascular diseases, having high prevalence rates, generating significant costs to countries, and has become a public health problem. 

Objetive:

The present study evaluated the effect of sage flour consumption (chia) on the indicators of metabolic syndrome in outpatients with dyslipidemia.

Material and methods:

A community trial was carried out with a control group, made up of patients aged 40 to 75 years who attended the medical office during the year 2023. The population was randomly divided into two groups, the intervention group, which received 25 g of daily Salvia hispánica (chia) flour, and the control group, which received nutritional treatment, both for a period of 30 days. Indicators of metabolic syndrome were evaluated according to ATPIII criteria. The statistical analysis used was Student's T and Mann-Whitney U tests.

Results:

The sample was made up of 24 patients, with a predominance of women in both groups with 70% in the control group and 64.3% in the intervention group, the predominance of ages was between 40 to 60 years, with 80% in the control group. and 85.7% in the intervention group, after 30 days of evaluation, no significant differences (p ≥ 0.05) were observed between the two groups, in any of the metabolic syndrome indicators.

Conclusions:

No significant differences were found after 30 days of intervention, between the control and intervention group, likewise, paradoxically a decrease in HDLc was observed in the intervened group and an increase in the control group, therefore, supplementation with Hispanic sage flour had no effect on the indicators of metabolic syndrome in patients with dyslipidemia.

References

Tejada López YO, Choquehuanca Zambrano GM, Goicochea Ríos E del S, Vicuña Villacorta JE, Guzmán Aybar OY. Perfil clínico-epidemiológico del síndrome metabólico en adultos atendidos en el hospital I Florencia de Mora EssaLUD. Horizonte Médico (Lima) [Internet]. 2020 [cited 2023 Set 17];20(4). Available from: http://www.scielo.org.pe/scielo.php?script=sci_abstract&pid=S1727-558X2020000400007&lng=es&nrm=iso&tlng=es

Adams KJ, Chirinos JL. Prevalencia de factores de riesgo para síndrome metabólico y sus componentes en usuarios de comedores populares en un distrito de Lima, Perú. Rev Peru Med Exp Salud Publica [nternet]. 2018 Apr. 5 [cited 2023 Set 17];35(1):39-45. vailable from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/3598

Instituto Nacional de Salud - INS [Internet]. 2020 [cited 2023 Dec 16]. Available from: https://www.gob.pe/ins

García-García FJ, Monistrol-Mula A, Cardellach F, Garrabou G. Nutrition, Bioenergetics, and Metabolic Syndrome. Nutrients [Internet]. 2020 Sep [cited 2023 Set 30];12(9):2785. Available from: https://www.mdpi.com/2072-6643/12/9/2785

Hernández-Sampieri R. Metodología de la investigación: las rutas cuantitativa, cualitativa y mixta [internet]. gob.mx. [cited 2023 Set 20]. Available from :http://www.biblioteca.cij.gob.mx/Archivos/Materiales_de_consulta/Drogas_de_Abuso/Articulos/SampieriLasRutas

Chiquito-Guale BM, Plúas-Vargas MP, Lucas-Parrales EN. Síndrome metabólico y hemoglobina glicosilada en Latinoamérica. MQRInvestigar [Internet]. 2023 Aug 29 [cited 2023 Set 20];7(3):3137–53. Available from: https://www.investigarmqr.com/ojs/index.php/mqr/article/view/609

Silva L de A, Verneque BJF, Mota APL, Duarte CK. Chia seed (Salvia hispanica L.) consumption and lipid profile: a systematic review and meta-analysis. Food Funct [Internet]. 2021 oct 4 [cited 2023 Oct 16];12(19):8835–49. Available from: https://pubs.rsc.org/en/content/articlelanding/2021/fo/d1fo01287h

McGraw Hill Medical [Internet]. [cited 2023 Nov 16]. Ensayo comunitario. Available from: https://accessmedicina.mhmedical.com/content.aspx?bookid=1464&sectionid=101050453

Mili N, Paschou SA, Goulis DG, Dimopoulos MA, Lambrinoudaki I, Psaltopoulou T. Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations. Endocrine [Internet]. 2021 Dec 1 [cited 2023 Nov 16];74(3):478–97. Available from: https://doi.org/10.1007/s12020-021-02884-x

Tejera C, Porca C, Rodriguez-Carnero G, Andújar P, Casanueva FF, Bellido D, et al. Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program. Nutrients [Internet]. 2022 Jan [cited 2023 Nov 15];14(5):1066. Available from: https://www.mdpi.com/2072-6643/14/5/1066

Mascaró CM, Bouzas C, Montemayor S, Casares M, Llompart I, Ugarriza L, et al. Effect of a Six-Month Lifestyle Intervention on the Physical Activity and Fitness Status of Adults with NAFLD and Metabolic Syndrome. Nutrients [Internet]. 2022 Jan [cited 2023 Nov 15];14(9):1813. Available from: https://www.mdpi.com/2072-6643/14/9/1813

Knez Hrnčič M, Ivanovski M, Cör D, Knez Ž. Chia Seeds (Salvia Hispanica L.): An Overview—Phytochemical Profile, Isolation Methods, and Application. Molecules [Internet]. 2020 Jan [cited 2023 Nov 16];25(1):11. Available from: https://www.mdpi.com/1420-3049/25/1/11

Rosales Romero KS, Soto Quispe ND. Efecto del consumo de chía en composición corporal, glucosa, perfíl lipídico e índices aterogénicos en universitarios. Repositorio Institucional - UNIFÉ [Internet]. 2021 [cited 2023 Nov 16]; Available from: https://repositorio.unife.edu.pe/repositorio/handle/20.500.11955/824

Lovato A de C. Avaliação clínica e laboratorial dos efeitos biológicos das sementes de chia (salvia hispanica l.) Em portadores de doenças crônicas e indivíduos saudáveis. 2021 Mar 26 [cited 2023 Nov 16]; Available from: https://repositorio.ufmg.br/handle/1843/42985

Tavera-Hernández R, Jiménez-Estrada M, Alvarado-Sansininea JJ, Huerta-Reyes M. Chia (Salvia hispanica L.), a pre-Hispanic food in the treatment of diabetes mellitus: Hypoglycemic, antioxidant, anti-inflammatory, and inhibitory properties of α-glucosidase and α-amylase, and in the prevention of cardiovascular disease. Molecules [Internet]. 2023;28(24):8069. Disponible en: http://dx.doi.org/10.3390/molecules28248069

Dickens B, Sassanpour M, Bischoff EL. The effect of Chia seeds on high-density lipoprotein (HDL) cholesterol. Cureus [Internet]. 2023; Disponible en: http://dx.doi.org/10.7759/cureus.40360

Khan G, Hussain MI, Gull KJ, Siddique A, Sheikh SI, Irfan T, et al. Effect of Salvia hispanica (Chia seeds) and Foeniculum vulgare (Fennel seeds) against weight-loss and lipid profile in obese human subjects. Pak J Pharm Sci [Internet]. 2024 [citado el 25 de junio de 2024];37(1(Special)). Disponible en: https://pubmed.ncbi.nlm.nih.gov/38747274/

Fernández-Martínez E, Lira-Islas IG, Cariño-Cortés R, Soria-Jasso LE, Pérez-Hernández E, Pérez-Hernández N. Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats. J Food Biochem [Internet]. 2019;43(9). Disponible en: http://dx.doi.org/10.1111/jfbc.12986

de Souza Ferreira C, de Sousa Fomes L de F, da Silva GES, Rosa G. Effect of chia seed (Salvia hispanica L.) consumption on cardiovascular risk factors in humans: a systematic review [Internet]. [citado el 25 de junio de 2024]. Disponible en: http://dx.doi.org/10.3305/nh.2015.32.5.9394

Teoh SL, Lai NM, Vanichkulpitak P, Vuksan V, Ho H, Chaiyakunapruk N. Clinical evidence on dietary supplementation with chia seed (Salvia hispanica L.): a systematic review and meta-analysis. Nutr Rev [Internet]. 2018;76(4):219–42. Disponible en: http://dx.doi.org/10.1093/nutrit/nux071

de Miranda DA, Pinheiro da Silva F, Carnier M, Mennitti LV, Figuerêdo RG, Hachul ACL, et al. Chia flour (Salvia hispanica L.) did not improve the deleterious aspects of hyperlipidic diet ingestion on glucose metabolism, but worsened glycaemia in mice. Food Res Int [Internet]. 2019; 121:641–7. Disponible en: http://dx.doi.org/10.1016/j.foodres.2018.12.033

Carnier J, Silva FP, de Miranda DA, Santamarina AB, Mennitti LV, Moreira RG, et al. Chia (Salvia hispanica L.) flour promotes beneficial effects on adipose tissue but not on glycaemic profile of diet‐induced obesity in mice. Eur J Lipid Sci Technol [Internet]. 2017;119(10). Disponible en: http://dx.doi.org/10.1002/ejlt.201600384

Creus A, Chicco A, Álvarez SM, Giménez MS, de Lombardo YB. Dietary Salvia hispanica L. reduces cardiac oxidative stress of dyslipidemic insulin-resistant rats. Appl Physiol Nutr Metab [Internet]. 2020;45(7):761–8. Disponible en: http://dx.doi.org/10.1139/apnm-2019-0769

Lovato A de C. Avaliação clínica e laboratorial dos efeitos biológicos das sementes de chia (salvia hispanica l.) Em portadores de doenças crônicas e indivíduos saudáveis. 2021 Mar 26 [cited 2024 Jul 10]; Available from: https://repositorio.ufmg.br/handle/1843/42985

Rosales Romero KS, Soto Quispe ND. Efecto del consumo de chía en composición corporal, glucosa, perfíl lipídico e índices aterogénicos en universitarios. Repositorio Institucional - UNIFÉ [Internet]. 2021 [cited 2024 Jul 10]; Available from: https://repositorio.unife.edu.pe/repositorio/handle/20.500.11955/824

Published

2024-11-25

How to Cite

ZAPATA SEQUEIROS, O. I., HUAMÁN GUTIERREZ, Óscar G., & PALOMINO QUISPE, L. P. (2024). Salvia hispanica (chia) flour and indicators of metabolic syndrome in outpatients with dyslipidemia: Farinha de chia e síndrome metabólica em pacientes com dislipidemia. Nutrición Clínica Y Dietética Hospitalaria, 44(4). https://doi.org/10.12873/444zapata

Issue

Section

Research articles

Categories

Most read articles by the same author(s)

1 2 3 4 > >>